	Actif À Court Terme		Date
Agenus	USD 133.95M	120.61M	2025-09
Amgen	USD 29.06B	1.17B	2025-12
Anika Therapeutics	USD 101.59M	2.27M	2025-09
Arrowhead Research	USD 1.17B	223.75M	2025-12
Baxter International	USD 6.87B	61M	2025-12
Bristol-Myers Squibb	USD 35.63B	2.41B	2025-09
Eli Lilly	USD 55.63B	6.44B	2025-12
Enanta Pharmaceuticals	USD 198.68M	5.65M	2025-12
Enviri Corporation	USD 769.24M	21.36M	2025-09
Gilead Sciences	USD 19.89B	1.05B	2025-12
GlaxoSmithKline	GBP 17.51B	332M	2025-12
Glaxosmithkline	GBP 23.98B	6.31B	2025-09
Heron Therapeutics	USD 229.4M	18.48M	2025-09
Insmed	USD 1.79B	137.6M	2025-12
Intrexon	USD 23.72M	45.04M	2024-06
Ionis Pharmaceuticals	USD 2.99B	471.01M	2025-12
Karyopharm Therapeutics	USD 89.75M	8.12M	2025-09
Ligand Pharmaceuticals	USD 832.27M	78.35M	2025-12
MacroGenics	USD 232.09M	27.15M	2025-09
Merck	USD 47.56B	10.49B	2025-09
Pacira	USD 547.97M	14.78M	2025-12
Pfizer	USD 46.92B	3.22B	2025-09
Rigel Pharmaceuticals	USD 214.93M	39.53M	2025-09
Sangamo BioSciences	USD 49.89M	12.3M	2025-06
Veracyte	USD 488.38M	39.15M	2025-12

Ligand Pharmaceuticals Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.